002166.SZ
莱茵生物
SZSE · Consumer Defensive · C 制造业 · CN
CNY 6.60
−2.08%Year over year
Reported trailing growth
- Revenue
- +9.2%
- EBITDA
- —
- EBIT
- +1.4%
- EPS
- -7.8%
- Free cash flow
- +4.3%
- Operating cash flow
- -11.2%
Forward estimates
Based on analyst estimates
- Revenue
- -40.2%
- EBITDA
- -83.4%
- EPS
- -90.5%
Three-year CAGR
- Revenue
- +13.4%
- EBITDA
- +0.6%
- EBIT
- -6.9%
- Net income
- -7.1%
- EPS
- -12.5%
- Free cash flow
- +95.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026